UBS Evidence Lab inside: Growth prospects not priced, upgrade to Buy

Research evidence excerpt

UBS Evidence Lab inside: Growth prospects not priced, upgrade to Buy

tement, pricing, and earnings data provided by

outside data vendors are subject to quality control and may also be adjusted to more closely

measure the underlying economics of firm performance. These adjustments provide

consistency when analyzing a single company across time, or analyzing multiple companies

across industries or national borders.

The default scenario that is produced by the HOLT valuation model establishes a warranted

price that represents the expected mean value for a security based upon empirically derived

fade algorithms that forecast a firm's future return on capital and growth rates over an

extended period of time. As the third-party data are updated, the warranted price updates

automatically. A company’s future achieved return on capital or growth rate may differ from

HOLT default forecast. Additional information about the HOLT methodology is available upon

request.

CFROI, CFROE, HOLT, HOLT Lens, HOLTfolio and “Powered by HOLT” are trademarks or

registered trademarks of UBS in the United States and other countries. HOLT is a corporate

performance and valuation service of UBS.

HOLT Business Resilience Dashboard (HBRD) Disclaimer

The HOLT Business Resilience Dashboard (HBRD) is constructed by applying systematic

processes on publicly available records and third-party data to generate quantitative

measures. The HBRD consistently assigns scores using a transparent combination of metrics

and weights across financial, environmental and governance inputs. Individual companies

can be scored on a global-size and/or region-size relative basis. The HBRD is also translated

into five textual assessments (e.g. “Highest” or “Lowest”) based on their quintile percentile

rank.